Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Assist Reprod Genet ; 24(12): 597-611, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18034299

RESUMEN

PURPOSE: To review the available treatments for women with significantly diminished ovarian reserve and assess the efficacy of different ovarian stimulation protocols. METHODS: Literature research performed among studies that have been published in the Pubmed, in the Scopus Search Machine and in Cohrane database of systematic reviews. RESULTS: A lack of clear, uniform definition of the poor responders and a lack of large-scale randomized studies make data interpretation very difficult for precise conclusions. Optimistic data have been presented by the use of high doses of gonadotropins, flare up Gn RH-a protocol (standard or microdose), stop protocols, luteal onset of Gn RH-a and the short protocol. Natural cycle or a modified natural cycle seems to be an appropriate strategy. Low dose hCG in the first days of ovarian stimulation has promising results. Molecular biology tools (mutations, single nucleotide polymorphisms (SNPs)) have been also considered to assist the management of this group of patients. CONCLUSIONS: The ideal stimulation for these patients with diminished ovarian reserve remains a great challenge for the clinician, within the limits of our pharmaceutical quiver.


Asunto(s)
Protocolos Clínicos , Infertilidad Femenina/terapia , Inducción de la Ovulación/métodos , Insuficiencia Ovárica Primaria/terapia , Andrógenos/administración & dosificación , Aspirina/uso terapéutico , Femenino , Fármacos para la Fertilidad Femenina/uso terapéutico , Hormona Folículo Estimulante/uso terapéutico , Hormona Liberadora de Gonadotropina/agonistas , Hormona Liberadora de Gonadotropina/antagonistas & inhibidores , Gonadotropinas/administración & dosificación , Hormona del Crecimiento/administración & dosificación , Humanos , Infertilidad Femenina/diagnóstico , Infertilidad Femenina/etiología , Hormona Luteinizante/uso terapéutico , Menopausia Prematura/fisiología , Ciclo Menstrual/efectos de los fármacos , Insuficiencia Ovárica Primaria/complicaciones , Pronóstico , Proteínas Recombinantes/uso terapéutico
2.
Eur J Contracept Reprod Health Care ; 11(1): 23-7, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16546813

RESUMEN

Every year, many women all over the world will undergo a hysterectomy, the removal of their uterus. The majority of hysterectomies are performed to treat conditions such as fibroids, heavy bleeding, endometriosis, adenomyosis and prolapse. A hysterectomy is not often a procedure that needs to be performed urgently, except in the case of cancer. Therefore, a woman considering the procedure should take time to investigate all her options, including other possible treatments. Deciding whether to have a hysterectomy can be a difficult and emotional process. Signs of depression may include severe and prolonged feelings of sadness and hopelessness; diminished interest in activities; significant weight loss or gain; insomnia; fatigue; and thoughts of death or suicide. Every person reacts differently, and reactions are a combination of emotional and physical responses. We still have much to learn about the effects of hysterectomy on sexual function. We investigated many studies published in different journals relative to this subject and we compare their results. Women are more likely to report improved sexual functioning after the surgery when their symptoms have been alleviated. A new hysterectomy procedure that 'spares' abdominal ligaments and nerves is quicker and results in less blood loss and shorter hospital stays and seems to respect the tissues more, without affecting the sexuality of the women.


Asunto(s)
Histerectomía/psicología , Sexualidad/psicología , Depresión/etiología , Femenino , Identidad de Género , Humanos , Histerectomía/efectos adversos , Disfunciones Sexuales Psicológicas/etiología , Disfunciones Sexuales Psicológicas/psicología
3.
Fetal Diagn Ther ; 20(6): 540-3, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16260892

RESUMEN

We report a rare case of acute severe thrombocytopenia and leukopenia, which first presented at 37 weeks' gestation. Based on clinical as well as on laboratory findings the diagnosis of systemic lupus erythematosus was made. The patient was successfully managed with an emergency transfusion of 6 units of platelets and intravenous immunoglobulin infusion followed by methylprednisolone administration. A caesarean section was performed at 39 weeks. The neonate was not thrombocytopenic at birth, nor at the age of 1 month.


Asunto(s)
Leucopenia/etiología , Lupus Eritematoso Sistémico/diagnóstico , Complicaciones del Embarazo , Trombocitopenia/etiología , Corticoesteroides/uso terapéutico , Adulto , Femenino , Humanos , Inmunoglobulinas Intravenosas/uso terapéutico , Leucopenia/diagnóstico , Leucopenia/terapia , Lupus Eritematoso Sistémico/complicaciones , Lupus Eritematoso Sistémico/tratamiento farmacológico , Metilprednisolona/uso terapéutico , Transfusión de Plaquetas , Embarazo , Complicaciones Hematológicas del Embarazo , Resultado del Embarazo , Trombocitopenia/diagnóstico , Trombocitopenia/terapia , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...